These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Bet on one big idea--or diversify? Stuart TE Harv Bus Rev; 2013 Nov; 91(11):131-5. PubMed ID: 24340875 [No Abstract] [Full Text] [Related]
15. Is it too late to save Schering? Simons J Fortune; 2003 Sep; 148(5):145-6, 148, 150. PubMed ID: 14509911 [No Abstract] [Full Text] [Related]
16. Inside Pfizer's palace coup. Did CEO Jeff Kindler get pushed out because he was shaking up the dysfunctional pharmaceutical giant--or because he was an ineffective leader? Elkind P; Reingold J; Burke D Fortune; 2011 Aug; 164(3):76-91. PubMed ID: 21879700 [No Abstract] [Full Text] [Related]
17. Stop the dollar worshiping. Keller BR Tex Med; 2001 Feb; 97(2):13-4. PubMed ID: 11233053 [No Abstract] [Full Text] [Related]
18. Folly or volley? Will a dollar $4 pill finally open the healthcare market to competitive pricing? Sturm AC Healthc Financ Manage; 2006 Nov; 60(11):120-2. PubMed ID: 17094287 [No Abstract] [Full Text] [Related]
19. Congress works to permit 'biosimilar' drugs very soon. Carroll J Manag Care; 2009 Apr; 18(4):7-8. PubMed ID: 19472559 [No Abstract] [Full Text] [Related]
20. Amgen's NESP victory cuts out Johnson & Johnson. Fürst I Nat Biotechnol; 1999 Feb; 17(2):124. PubMed ID: 10052335 [No Abstract] [Full Text] [Related] [Next] [New Search]